Activated protein C protects against pressure overload-induced hypertrophy through AMPK signaling
Creators
- 1. Department of Physiology and Biophysics, Mississippi Center for Heart Research, University of Mississippi Medical Center, Jackson, MS 39216 (United States)
- 2. Department of Pharmacology and Toxicology, SUNY Buffalo, Buffalo, NY 14214 (United States)
- 3. The First Affiliated Hospital, Jilin University, Changchun 130012 (China)
- 4. School of Life Sciences, Lanzhou University, Lanzhou 730000 (China)
- 5. Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104 (United States)
Description
Highlights: • Cardiac AMPK protects against pressure overload-induced hypertrophy. • The signaling function of APC protects against pressure overload-induced hypertrophy. • APC decreases inflammatory reactions and cardiac ROS generation induced by pressure overload. We found that the anticoagulant plasma protease, activated protein C (APC), stimulates the energy sensor kinase, AMPK, in the stressed heart by activating protease-activated receptor 1 (PAR1) on cardiomyocytes. Wild-type (WT) and AMPK-kinase dead (KD) transgenic mice were subjected to transverse aortic constriction (TAC) surgery. The results demonstrated that while no phenotypic differences can be observed between WT and AMPK-KD mice under normal physiological conditions, AMPK-KD mice exhibit significantly larger hearts after 4 weeks of TAC surgery. Analysis by echocardiography suggested that the impairment in the cardiac function of AMPK-KD hearts is significantly greater than that of WT hearts. Immunohistochemical staining revealed increased macrophage infiltration and ROS generation in AMPK-KD hearts after 4 weeks of TAC surgery. Immunoblotting results demonstrated that the redox markers, pShc66, 4-hydroxynonenal and ERK, were all up-regulated at a higher extent in AMPK-KD hearts after 4 weeks of TAC surgery. Administration of APC-WT and the signaling selective APC-2Cys mutant, but not the anticoagulant selective APC-E170A mutant, significantly attenuated pressure overload-induced hypertrophy and fibrosis. Macrophage infiltration and pShc66 activation caused by pressure overload were also inhibited by APC and APC-2Cys but not by APC-E170A. Therefore, the cardiac AMPK protects against pressure overload-induced hypertrophy and the signaling selective APC-2Cys may have therapeutic potential for treating hypertension-related hypertrophy without increasing the risk of bleeding.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.bbrc.2017.12.125Additional details
Identifiers
- DOI
- 10.1016/j.bbrc.2017.12.125;
- PII
- S0006291X17325251;
Publishing Information
- Journal Title
- Biochemical and Biophysical Research Communications
- Journal Volume
- 495
- Journal Issue
- 4
- Journal Page Range
- p. 2584-2594
- ISSN
- 0006-291X
- CODEN
- BBRCA9
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 54056851
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- ANTICOAGULANTS; MACROPHAGES; PHOSPHOTRANSFERASES; RECEPTORS; TRANSGENIC MICE
- Descriptors DEC
- ANIMAL CELLS; ANIMALS; CONNECTIVE TISSUE CELLS; DRUGS; ENZYMES; HEMATOLOGIC AGENTS; MAMMALS; MEMBRANE PROTEINS; MICE; ORGANIC COMPOUNDS; PHAGOCYTES; PHOSPHORUS-GROUP TRANSFERASES; PROTEINS; RODENTS; SOMATIC CELLS; TRANSFERASES; TRANSGENIC ANIMALS; VERTEBRATES
Optional Information
- Copyright
- Copyright (c) 2017 Elsevier Inc. All rights reserved.